Molecular Mechanisms of Pharmaconutrients

Journal of Surgical Research

Volumn 161, Issue 2, 2010, Pages 288-294

  Santora, Rachel ^a   Kozar, Rosemary A ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

antioxidants; arginine; glutamine; immune enhancing formulas; omega 3 fatty acids; pharmaconutrients

Indexed keywords

ANTIOXIDANT; ARGININE; GLUTAMINE; NUCLEOTIDE; OMEGA 3 FATTY ACID; RNA; URACIL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TARGETING; ENTERIC FEEDING; GRAFT REJECTION; HEMORRHAGIC SHOCK; HOSPITAL INFECTION; HUMAN; IMMUNOMODULATION; INFECTION PREVENTION; INFECTIOUS COMPLICATION; MULTIPLE ORGAN FAILURE; NONHUMAN; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPTIC SHOCK; SHOCK;

AMINO ACIDS; ANIMALS; ANTIOXIDANTS; ARGININE; CRITICAL ILLNESS; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; GLUTAMINE; HUMANS; NUCLEOTIDES; NUTRITIONAL SUPPORT; PPAR GAMMA; RETINOID X RECEPTORS;

EID: 77951937948     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.06.024     Document Type: Review

References (67)

1. Grossie Jr. V.B., Weisbrodt N.W., Moore F.A., et al. Ischemia/reperfusion-induced disruption of rat small intestine transit is reversed by total enteral nutrition. Nutrition 17 (2001) 939
2. Moore F. Effects of immune enhancing diets on infectious morbidity and multiple organ failure. J Parenter Enteral Nutr 25 2 Suppl (2001) S36
3. www.criticalcarenutrition.com
4. Moore F.A., Sauaia A., Moore E.E., et al. Post injury multiple organ failure: A bimodal phenomenon. J Trauma 40 (1996) 501
5. Wischmeyer P.E. Glutamine: Mode of action in critical illness. Crit Care Med 35 Suppl. (2007) S541
6. Wischmeyer P.E. The glutamine story: Where are we now?. Current Opin Crit Car 12 (2006) 142
7. Kles K.A., and Tappenden K.A. Hypoxia differentially regulates nutrient transport in rat jejunum regardless of luminal nutrient present. Am J Physiol Gastrointest Liver Physiol. 283 (2002) G1336
8. Choudry H.A., Souba W.W., Lin C.M., et al. Stimulation of expression of the intestinal glutamine transporter ATB° in tumor-bearing rats. Ann Surg Onc 13 (2006) 1747
9. Houdijk A.P., Rijnsburger E.R., Jansen J., et al. Randomized trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 352 (1998) 772
10. Boelens P.G., Melis G.C., van Leeuwen P.A., et al. Route of administration (enteral or parenteral) affects the contribution of L-glutamine to de novo L-arginine synthesis in mice: A stable-isotope study. Am J Physiol. Endocrin Metab 291 (2006) E683
11. Poll V.d., Siroen M.P., van Leeuwen P.A., et al. Interorgan amino acid exchange in humans: Consequences for arginine and citrulline metabolism. Am J Clin Nutr 85 (2007) 167
12. De-Souza D.A., and Greene L.J. Intestinal permeability and systematic infections in critically ill patients: Effect of glutamine. Crit Care Med 33 (2005) 1125
13. Novak F., Heyland D.K., Avenell A., et al. Glutamine supplementation in serious illness: A systematic review of the evidence. Crit Care Med 30 (2002) 2022
14. Houdijk A.P.J., Rijnsburger E.R., Jansen J., et al. Randomized trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 352 (1998) 772
15. Garrel D., Patenaude J., Nedelec B., et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: A prospective, controlled, randomized clinical trial. Crit Care Med 31 (2003) 2444
16. Zhou Y., Jiang Z., Sun Y., et al. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: A randomized, double-blind, controlled clinical trial. JPEN 27 (2003) 241
17. Conejero R., Bonet A., Grau T., et al. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: A randomized, single-blind, prospective, multicenter study. Nutrition 18 (2002) 716
18. McQuiggan M., Kozar R., Sailors R.M., et al. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. J Parent Enteral Nut 32 (2008) 28
19. Estivariz C.F., Griffith D.P., Luo M., et al. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. J Parenter Enteral Nutr 32 (2008) 389
20. Griffiths R.D., Allen K.D., Andrews F.J., et al. Infection, multiple organ failure, and survival in the intensive care unit: Influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition 17 (2002) 546
21. Kozar R.A., Schultz S.G., Hassoun H.T., et al. The type of sodium-coupled solute modulates small bowel mucosal injury, transport function and ATP after Ischemia/reperfusion injury in rats. Gastroenterology 123 (2002) 810
22. Sato N., Moore F.A., Smith M.A., et al. Differential induction of PPAR{gamma} by luminal glutamine and iNOS by luminal arginine in the rodent post ischemic small bowel. Am J Physiol Gastrointest Liver Physiol 290 (2006) 616
23. Altmann R., Hausmann M., Spottl T., et al. 13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cells. Biochem Pharmacol 74 (2007) 612
24. Huang J.T., Welch J.S., Ricote M., et al. Interleukin-4 dependent production of PPAR gamma ligands in macrophages by 12/15-liopenase. Nature 400 (1999) 378
25. Ricote M., Li A.C., Willson T.M., et al. The peroxisome proliferators-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 (1998) 79
26. Wischmeyer P.E., Kahana M.D., Wolfson R., et al. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 90 (2001) 2403
27. Hartl F. Molecular chaperones in cellular protein folding. Nature 381 (1996) 571
28. Musch M.W., Hayden D., Sugi K., et al. Cell-specific induction for hsp72-mediated protection by glutamine against oxidant injury in IEC 18 cells. Proc Assoc Am Phys 110 (1998) 136
29. Wischmeyer P.E., Kahana M.D., Vandehoek T.L., et al. Glutamine reduces cell death and induces recovery of contractile function in cardiac myocytes after ischemia/reperfusion injury. Crit Care Med 28 (2001) A33
30. Singleton K.D., Beckey V.E., and Wischmeyer P.E. Glutamine prevents activation of NF-κB and stress kinas pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 24 (2005) 583
31. Lai Y.N., Yeh S.L., Lin M.T., et al. Glutamine supplementation enhances mucosal immunity in rats with gut-derived sepsis. Nutrition 20 (2004) 286
32. Ckless K., van der Vliet A., and Janssen-Heininger Y. Oxidative-nitrosative stress and post-translational protein modifications: Implications to lung structure-function relations. Arginase modulates NF-κB activity via a nitric oxide-dependent mechanism. Am J Respir Cell Mol Biol 36 (2007) 645
33. Yoo P.K., Aguirre C.C., Tsoa R.W., et al. Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications. J Histochem Cytochem 51 (2003) 1151
34. Chang C.I., Liao J.C., and Kuo L. Arginase modulates nitric oxide production in activated macrophages. Am J Physiol 274 (1998) H342
35. Ochoa J.B., Bernard A.C., O'Brien W.E., et al. Arginase 1 expression and activity in human mononuclear cells after injury. Ann Surg 233 (2001) 393
36. Popovic P., Zeh H.J., and Ochoa J.B. Arginine and Immunity. J Nutr 137 (2007) 1681S
37. Bansal V., and Ochoa J.B. Arginine availability, arginase and the immune response. Curr Opin Clin Nutr Metab Care 6 (2003) 223
38. Heyland D.K., and Samis A. Does immunonutrition in patients with sepsis do more harm than good?. Intensive Care Med 29 (2003) 667
39. Sato N., Moore F.A., Kone B.C., et al. Differential induction of PPAR-γ by luminal glutamine and iNOS by luminal arginine in the rodent post ischemic small bowel. Am J Physiol Gastrointest Liver Physiol 290 (2006) G616
40. Ward D.T., Lawson S.A., Gallagher C.M., et al. Sustained nitric oxide production via L-arginine administration ameliorates effect of intestinal ischemia-reperfusion. J Surg Res 89 (2000) 13
41. Mailman D. Modulation of hemorrhagic shock by intestinal mucosal N-nitro-L arginine and L-arginine in the anesthetized rat. Shock 12 (1999) 155
42. Hua T.C., and Moochhala S.M. Influence of L-arginine, aminoguanidine, and NG-nitro-L-arginine methyl ester (L-name) on the survival rate in a rat model of hemorrhagic shock. Shock 11 (1999) 51
43. Daughters K., Waxman K., and Nguyen H. Increasing nitric oxide production improves survival in experimental hemorrhagic shock. Resuscitation 31 (1996) 141
44. Fukatsu K., Ueno C., Maeshima Y., et al. Effects of L-arginine infusion during ischemia on gut perfusion, oxygen tension, and circulating myeloid cell activation in murine gut ischemia/ reperfusion model. JPEN J Parenter Enteral Nutr 228 (2004) 224
45. Jacob T.D., Ochoa J.B., Udekwu A.O., et al. Nitric oxide production is inhibited in trauma patients. J Trauma 35 (1993) 590
46. Cosgrove M. Perinatal and infant nutrition. Nucleotides. Nutrition 14 (1998) 748
47. Gil A. Modulation of the immune response mediated by dietary nucleotides. Eur J Clin Nutr 56 Suppl 3 (2002) S1
48. Iwasa Y., Iwasa M., Ohmori Y., et al. The effect of the administration of nucleosides and nucleotides for parenteral use. Nutrition 16 (2000) 598
49. Kulkarni A.D., Rudolph F.B., and Van Buren C.T. The role of dietary sources of nucleotides in immune function: Review. J Nutr 124 8 Suppl (1994) 1442S
50. Van Buren C.T., Kulkarni A.D., and Rudolph F.B. The role of nucleotides in adult nutrition. J Nutr 124 1 Suppl (1994) 160S
51. Uauy R., Quan R., and Gil A. Role of nucleotides in intestinal development and repair: Implications for infant nutrition. J Nutr 124 8 Suppl (1994) 1436S
52. Kulkarni A., Fanslow W., Higley H., et al. Expression of the immune cell surface markers in vivo and immune competence in mice by dietary nucleotides. Transplan Proc 21 (1989) 121
53. Furst P., and Kuhn K. Fish oil emulsions: What benefits can they bring?. Clinical Nutrition 19 (2000) 7
54. Razzak A., Aldrich C., Babcock T.A., et al. Attenuation of iNOS in an LPS-stimulated macrophage model by omega-3 fatty acids is independent of COX-2 derived PGE2. J Surg Res 145 (2008) 344
55. Novak T., Babcock T.A., Jho D.H., et al. NF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription. Am J Physiol Lung Cell Mol Physiol 284 (2003) L84
56. Babcock T.A., Kurland A., Helton W.S., et al. Inhibition of activator protein-1 transcription factor activation by ω-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. J Parenter Enteral Nutr 27 (2003) 176
57. Aldridge C., Razzak A., Babcock T.A., et al. Lipopolysaccharide-stimulated RAW 264.7 macrophage inducible nitric oxide synthase and nitric oxide production is decreased by and omega-3 fatty acid lipid emulsion. J Surg Res 149 (2008) 296
58. Singer P., Theilla M., Fisher H., et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and γ-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 34 (2006) 1033
59. Pontes-Arruda A., Aragao A.M., and Albuquerque J.D. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 34 (2006) 2325
60. Gadek J.E., DeMichele S.J., Karlstad M.D., et al. Effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 27 (1999) 1409
61. Heyland D.K., Dhaliwal R., Day A.G., et al. Reducing Deaths due to Oxidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 65 (2006) 250
62. Forceville X., Vitoux D., Gauzit R., et al. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Car Med 26 (1998) 1536
63. Goode H.F., Cowley H.C., Walker B.E., et al. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 23 (1995) 646
64. Nathens A.B., Neff M.J., Jurkovich G.J., et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 236 (2002) 814
65. Collier B.R., Giladi A., Dossett L.A., et al. Impact of High-dose antioxidants on outcomes in acutely injured patients. J Parenter Enteral Nutr 32 (2008) 384
66. Heyalnd D.K., Dhaliwal R., Suchner U., et al. Antioxidant nutrients: A systemic review of trace elements and vitamins in the critically ill patient. Int Care Med 31 (2005) 327
67. Heyland D.K., Dhaliwalm R., Day A., et al. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: A phase I dose-finding study. J Parenter Enteral Nutr 31 (2007) 109